SLA 1.12% $4.50 silk laser australia limited

holding up well, page-57

  1. 974 Posts.
    lightbulb Created with Sketch. 35
    Marcj you seem to know something about Roche pharmacuticals and their new trial.
    Do you have answers to these questions?

    1 How far away is this from market
    2 Are there any known side effects to the treatment
    3 Do they have pricing arranged
    4 Is Hep C the only disease it targets
    5 What percentage of people is it effective in treating.

    I suffer from mild asthma and the amount of times over the years I've heard about trials of a new product to cure it is amazing.
    I'm still waiting for a cure!
    SLA are at the brink of releasing Ropren which is a company making product.
    Ropren helps the immune system fight of a number of diseases including liver disease so even though Roche pharmacutical's might have a new product for Hep C (which could be years away) it wont have a huge impact if any on Ropren sales.

 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.